留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

益气养阴法联合吉西他滨对老年晚期非小细胞肺癌生活质量的影响

陈黎 李红 邱婷 吴峰妹 张颖 蔡敏

陈黎, 李红, 邱婷, 吴峰妹, 张颖, 蔡敏. 益气养阴法联合吉西他滨对老年晚期非小细胞肺癌生活质量的影响[J]. 南京中医药大学学报, 2016, 32(4): 330-333.
引用本文: 陈黎, 李红, 邱婷, 吴峰妹, 张颖, 蔡敏. 益气养阴法联合吉西他滨对老年晚期非小细胞肺癌生活质量的影响[J]. 南京中医药大学学报, 2016, 32(4): 330-333.
CHEN Li, LI Hong, QIU Ting, WU Feng-mei, ZHANG Ying, CAI Min. Influences of Reinforcing Qi and Nourishing Yin Method Combined with Gemcitabine on Quality of Life of Senile Patients with Advanced Non-small Cell Lung Cancer[J]. Journal of Nanjing University of traditional Chinese Medicine, 2016, 32(4): 330-333.
Citation: CHEN Li, LI Hong, QIU Ting, WU Feng-mei, ZHANG Ying, CAI Min. Influences of Reinforcing Qi and Nourishing Yin Method Combined with Gemcitabine on Quality of Life of Senile Patients with Advanced Non-small Cell Lung Cancer[J]. Journal of Nanjing University of traditional Chinese Medicine, 2016, 32(4): 330-333.

益气养阴法联合吉西他滨对老年晚期非小细胞肺癌生活质量的影响

Influences of Reinforcing Qi and Nourishing Yin Method Combined with Gemcitabine on Quality of Life of Senile Patients with Advanced Non-small Cell Lung Cancer

  • 摘要: 目的 观察中医益气养阴法联合吉西他滨化疗,对老年晚期非小细胞肺癌(NSCLC)生活质量、免疫功能等的影响。方法 60例老年晚期NSCLC患者,随机分为治疗组31例(益气养阴抗瘤方联合吉西他滨)和对照组29例(吉西他滨),记录2组患者观察期间生活质量、临床症状、化疗毒副反应、免疫功能等变化。结果 治疗后治疗组躯体功能、角色功能、整体生活质量评分均高于对照组(P<0.01);治疗组呼吸困难、失眠、食欲丧失等症状评分低于对照组(P<0.05~0.01);咳嗽、气短、口干咽燥等症状缓解明显优于对照组(P<0.01);治疗组血清免疫功能部分改善,与对照组相比,P<0.01;治疗组化疗不良反应低于对照组(P<0.05)。结论 中医益气养阴治法联合吉西他滨化疗能有效治疗老年晚期NSCLC,改善临床症状,提高生活质量,减少治疗中的不良反应。

     

  • [1] QUOIX E,WESTEEL V,ZALCMAN G,et al.Chemotherapy in elderly patients with advanced non-small cell lung cancer[J].Lung Cancer,2011,74:364-368.
    [2] GAJRA A, LICHTMAN SM. Treatment of advanced lung cancer in the elderly[J]. Hosp Pract (1995), 2011, 39(2): 107-115.
    [3] 中华人民共和国医政司.常见恶性肿瘤诊治规范[S].北京:中国协和医科大学出版社,1999: 773-781.
    [4] Department of Medical Administration of PRC. Specification for Diagnosis and Treatment of Common Malignant Tumors[S]. Beijing: Pecking union medical college press, 1999: 773-781.
    [5] MOUNAIN CF. Revisions in the international system for staging lung cancer[J]. Chest, 1997, 111(6): 1486-1487.
    [6] 中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:383-385,216-221.
    [7] Chinese Traditional Medicine New Medicine Clinical Research Guiding Principles[M]. Beijing: Chinese medical science and technology press, 2002 : 383-385, 216-221.
    [8] SPRANGERS M, CULL A, GROENVOLD M, et al. The European organization for research and treatment of cancer approach to developing questionnaire modules: an update and overview[J]. Quality Life Res, 1998, 7(4): 291-300.
    [9] 中国肿瘤防治办公室.中国常见恶性肿瘤诊治规范[M].北京:北京医科大学、中国协和医科大学联合出版社,1993:13.
    [10] National Office for Cancer Prevention and Control in China. Specification for Diagnosis and Treatment of Common Malignant Tumors in China[M]. Beijing: Beijing medical university and China xie-he medical university joint publishing house, 1993: 13.
  • 加载中
计量
  • 文章访问数:  879
  • HTML全文浏览量:  2
  • PDF下载量:  640
  • 被引次数: 0
出版历程
  • 刊出日期:  2016-07-10

目录

    /

    返回文章
    返回